TMFBiologyFool

Brian Orelli

Somewhere between his graduate thesis on BRCA1, a gene that causes hereditary breast cancer, and his postdoctoral fellowship in DNA repair, Brian realized he enjoyed analyzing other people's data more than running his own experiments. Having gotten his first taste of how to analyze stocks from The Motley Fool many years prior, it was only fitting that he came full circle and started writing about biotech, pharmaceutical, and medical device companies for Fool.com. He also covers the health insurance industry to keep from going into binary-event overload. When not writing at The Motley Fool or trade journals like Nature Biotechnology and BioWorld, Brian can be found coaching soccer or hanging out at the beach in his hometown of San Diego.

TMFBiologyFool’s Activity

Today

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 3 hours ago

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 3 hours ago

Yesterday

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 4:14 PM

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 3:54 PM

NL

Article

TMFBiologyFool published an article 3:16 PM

Why Alnylam Pharmaceuticals, Inc. Competed Higher Today

One biotech's bad luck is another biotech's good fortune.

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 1:50 PM

NL

Article

TMFBiologyFool published an article 1:34 PM

Why Ionis Pharmaceuticals Plummeted Today

Severe platelet declines in two of its drugs rock the stock.

Wed May 25

Rule Breakers Boards Post

TMFBiologyFool replied to the Rule Breakers boards. 6:33 PM

Tue May 24

NL

Article

TMFBiologyFool published an article 4:20 PM

Better Buy: Alnylam Pharmaceuticals, Inc. vs. Ionis Pharmaceuticals Inc.

A battle of the RNA-targeting drugmakers.

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 12:31 PM

Mon May 23

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 12:45 PM

Fri May 20

Supernova article.

TMFBiologyFool published an . 10:04 PM

Tue May 17

Rule Breakers Boards Post

TMFBiologyFool replied to the Rule Breakers boards. 11:31 AM

Mon May 16

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 7:34 PM

Thu May 12

NL

Article

TMFBiologyFool published an article 9:20 PM

Emergent BioSolutions Inc in Transition

The biodefense company prepares for higher revenue and lower costs.

Rule Breakers article.

TMFBiologyFool published an update. 8:46 PM

Rule Breakers article.

TMFBiologyFool published an update. 8:36 PM

NL

Article

TMFBiologyFool published an article 7:48 PM

bluebird bio Inc: Catnapping in Cambridge

A sleepy first-quarter update from the biotech.

NL

Article

TMFBiologyFool published an article 4:50 PM

Exelixis, Inc. Prepares for Blastoff

The biotech launches Cabometyx for kidney cancer.

Rule Breakers article.

TMFBiologyFool published an update. 4:07 PM

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 85.58
Player Rank 10800 out of 74878
Score 506.45
Score Change Today -13.57
Accuracy 67.14%
Active Picks 73
Total Picks 215
Best Pick MNKD (+235.52)
Worst Pick INCY (-777.82)
Average Score per Pick 2.36
Charms Earned 9
Highest Rated Favorite zzlangerhans
Go to TMFBiologyFool’s CAPS page

Boards Stats & Trivia

Big red star, 1000 posts CAPS All Star SN Explorer 1 Mission Team Member SN Odyssey
Board Posts 1209
Recs Received 1652
People who have rec'd these posts 552
Recs to Posts Ratio (last 30 days) 3.00
Threads Started 130
Threads Started Percentage 10.75 %
Most Frequent Board Buying or Selling a Home
Very First Post Re: How many is enough? (6/6/2001)
Percentage of Posts Rec'd 54.26 %
Show TMFBiologyFool’s 10 Latest Posts